Daily biotech news, content, and exclusive interviews.
Joined May 2023
- Tweets 2,456
- Following 41
- Followers 11,568
- Likes 871
2,254 Photos and videos
๐๐๐ ๐๐๐๐: After presenting early in vivo CAR-T data showing promising results in 6 patients at #EHA2026, @LegendBiotech CEO Ying Huang discusses the future of these types of treatments. $LEGN
Watch the full interview: biotechtv.com/post/legend-biโฆ
2
4
9
971
๐๐๐ ๐๐๐๐: @LegendBiotech CEO Ying Huang discusses the company's late-breaking in vivo CAR-T #EHA2026 presentation showing a 6/6 overall response and 5/6 complete response at the highest dose level in NHL. $LEGN
Watch the full interview: biotechtv.com/post/legend-biโฆ
1
7
829
19h
๐๐๐๐ค ๐ข๐ง ๐๐๐ฏ๐ข๐๐ฐ: With M&A news like GSK's $10.6B acquisition of Nuvalent and more positive clinical trial data in pancreatic cancer, biotech mostly outperformed the broader market this week.
$TNGX $NUVL $ELVN $HUMA $CNTX
Link to video: biotechtv.com/post/biotech-mโฆ
3
11
1,454
19h
๐๐๐ ๐๐๐๐: With its myelofibrosis data now out, @Karyopharm's next big event is a key trial readout in endometrial cancer that is scheduled for mid-year. CEO Richard Paulson previews it for us. $KPTI
Watch the full interview: biotechtv.com/post/karyopharโฆ
1
11
1,483
20h
๐๐๐ ๐๐๐๐: @Karyopharm is hoping to add two new indications for selinexor over the near term - they just presented the phase 3 for the first one, myelofibrosis, at ASCO with an encore at #EHA2026. $KPTI
Full video: biotechtv.com/post/karyopharโฆ
4
15
2,239
Jun 12
๐๐๐ ๐๐๐๐: Earlier this week, there was a high profile acquisition of a degrader-antibody conjugate company. @Nurix_Tx CEO Arthur Sands, who is also pioneer on this, describes the scientific idea behind it. $NRIX
Watch the full interview: biotechtv.com/post/nurix-theโฆ
1
13
3,379
Jun 12
๐๐๐ ๐๐๐๐: @Nurix_Tx CEO Arthur T. Sands discusses this week's big collaboration deal with Roche, and highlights the company's #EHA2026 data and broader platform. $NRIX
Full video: biotechtv.com/post/nurix-theโฆ
3
7
4,388
Jun 12
๐๐๐ ๐๐๐๐: @CaribouBio's CEO Rachel Haurwitz on trying to convince Wall Street to see her vision on allogeneic CAR-T. #EHA2026 $CRBU
See the full interview: biotechtv.com/post/caribou-bโฆ
2
2
13
2,209
Jun 12
๐๐๐ ๐๐๐๐: @CaribouBio's CEO Rachel Haurwitz shares an #EHA2026 update on her company's CD19 and BCMA allogeneic CAR-T programs. $CRBU
Full video: biotechtv.com/post/caribou-bโฆ
1
1
21
3,523
Jun 11
๐๐๐ ๐๐๐๐: Touring the Nobel Prize Museum in Stockholm. Thanks to our host @Mavatar_AB / @camilagdeblois for inviting BiotechTV to be there.
1
6
18
2,791
Jun 11
๐
๐ซ๐จ๐ฆ ๐๐จ๐ง๐๐จ๐ง: Alceus Bio is working on an in vivo CAR-T platform for solid tumors and recently was a recipient of a golden ticket award from AbbVie.
Full video: biotechtv.com/post/alceus-biโฆ
1
7
1,894
Jun 11
๐
๐ซ๐จ๐ฆ ๐๐จ๐ง๐๐จ๐ง: Anomer Bio has a small molecule platform that aims to change how cells make and process glycans.
Full video: biotechtv.com/post/anomer-biโฆ
2
10
2,136
Jun 10
๐
๐ซ๐จ๐ฆ ๐๐๐ฆ๐๐ซ๐ข๐๐ ๐, ๐๐: PlaqueTec Ltd.'s has a unique liquid biopsy system and multi omic analysis approach that aims to profile the underlying biology of atherosclerosis.
Full video: biotechtv.com/post/plaquetecโฆ
3
8
2,227
Jun 9
๐
๐ซ๐จ๐ฆ ๐๐ฎ๐ง๐: @AsgardThx aims to turn tumor cells into a type of dendritic cell inside the body with that the immune system can learn the tumor's signature and fight it systemically.
Full video: biotechtv.com/post/asgard-thโฆ
4
18
10,206
Jun 9
๐
๐ซ๐จ๐ฆ ๐๐ฎ๐ง๐: Lund based BioInvent has had a busy week with a presentation of one program in ovarian cancer at ASCO, and two more coming up in hematological cancers at the upcoming EHA Congress.
Full video: biotechtv.com/post/bioinventโฆ
1
3
11
2,615